LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
LEMAITRE VASCULAR INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$82.31+1.49 (+1.84%)
Close on Oct 19, 2026
- Market cap
- $2.02B
- P/E (TTM)
- 28.9
- Dividend yield
- 0.97%
LEMAITRE VASCULAR INC revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $159.67M | $144.58M | $130.31M | $109.44M | $102.27M | $81.47M | $69.36M | $63.65M | $62.70M | – | 64.0% | +10.4% |
| United States | $141.57M | $128.74M | $117.81M | $99.46M | $93.87M | $75.22M | $63.13M | $59.08M | $58.47M | $50.44M | 56.7% | +10.0% |
| Europe, Middle East and Africa | $73.12M | $59.97M | $51.10M | $41.85M | $42.13M | $39.19M | $39.48M | $35.32M | $32.52M | – | 29.3% | +21.9% |
| Other countries | $61.67M | $52.07M | $42.91M | $36.79M | $35.49M | $36.37M | $41.70M | $34.05M | $30.82M | $28.36M | 24.7% | +18.4% |
| Germany | $17.90M | $14.42M | $13.42M | $11.22M | $12.97M | $12.37M | $12.40M | $12.45M | $11.58M | $10.35M | 7.2% | +24.1% |
| Asia Pacific | $16.82M | $15.31M | $12.08M | $10.36M | $10.03M | $8.70M | $8.39M | $6.60M | $5.65M | – | 6.7% | +9.8% |
| Canada | $15.25M | $13.67M | $10.79M | $8.34M | $7.05M | $5.41M | – | – | – | – | 6.1% | +11.6% |
| United Kingdom | $13.22M | $10.96M | $8.56M | $5.84M | $5.05M | – | – | – | – | – | 5.3% | +20.6% |
From the segment and revenue-disaggregation notes of Lemaitre Vascular's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.